De Wel, Bram
Goosens, Veerle
Sobota, Atka
Van Camp, Elke
Geukens, Ellen
Van Kerschaver, Griet
Jagut, Marlène
Claes, Kathleen
Claeys, Kristl G. http://orcid.org/0000-0001-9937-443X
Funding for this research was provided by:
Biogen
Article History
Received: 15 July 2020
Revised: 30 August 2020
Accepted: 8 September 2020
First Online: 15 September 2020
Compliance with ethical standards
:
: KGC received advisory board honoraria from Alnylam, Biogen, CSL Behring, Sanofi-Genzyme and travel reimbursement from Sanofi-Genzyme, unrelated to this work. The other authors report no conflicts of interest.
: Written informed consent was obtained from the patients. Both the Ethics Committee Research UZ/KU Leuven and the Belgian Federal Agency for Medicines and Health Products (FAGG) approved the study (EudraCT-nr: 2019-005007-40), which has therefore been performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments.